Suppr超能文献

在存在钙调蛋白拮抗剂苯氧苄胺和蜂毒素的情况下,通过用喹啉2和内源性酪氨酸的停流荧光法测量钙调蛋白及其C端或N端片段的钙释放。对心肌肌浆网钙调蛋白依赖性蛋白激酶的抑制作用。

Calcium release from calmodulin and its C-terminal or N-terminal halves in the presence of the calmodulin antagonists phenoxybenzamine and melittin measured by stopped-flow fluorescence with Quin 2 and intrinsic tyrosine. Inhibition of calmodulin-dependent protein kinase of cardiac sarcoplasmic reticulum.

作者信息

Suko J, Wyskovsky W, Pidlich J, Hauptner R, Plank B, Hellmann G

出版信息

Eur J Biochem. 1986 Sep 15;159(3):425-34. doi: 10.1111/j.1432-1033.1986.tb09904.x.

Abstract

Calcium dissociation from the C-terminal and N-terminal halves of calmodulin, intact bovine brain calmodulin and the respective phenoxybenzamine complexes or melittin complexes was measured directly by stopped-flow fluorescence with the calcium chelator Quin 2 and, when possible, also by protein fluorescence using endogenous tyrosine fluorescence by mixing with EGTA. Calcium dissociation from the C-terminal half of calmodulin, which contains only the two high-affinity calcium-binding sites, and from intact calmodulin was monophasic, with good correlation of the rates of calcium dissociation obtained by the two methods. The apparent rates with Quin 2 and endogenous tyrosine fluorescence were 13.4 s-1 and 12.8 s-1, respectively, in the C-terminal half and 10.5 s-1 and 10.8 s-1, respectively, in intact calmodulin (pH 7.0, 25 degrees C, 100 mM KCl). Alkylation of the C-terminal half resulted in a biphasic calcium dissociation (Quin 2: kobs 1.90 s-1 and 0.73 s-1 respectively; tyrosine: kobs 1.65 s-1 and 0.61 s-1 respectively). Alkylation of intact calmodulin resulted in a four-phase calcium dissociation measured with Quin 2 (kobs 85.3 s-1, 11.1 s-1, 1.92 s-1 and 0.59 s-1); the latter two phases are assumed to represent calcium release from high-affinity sites since they correspond to the biphasic tyrosine fluorescence change in intact alkylated calmodulin (kobs 2.04 s-1 and 0.53 s-1 respectively) and the rate parameters determined in the C-terminal half. Evidently perturbation of the calcium-binding sites by alkylation reduces the rate of calcium dissociation and allows a distinction to be made between dissociation from each of the two high-affinity sites as well as the distinct conformational change on dissociation of each calcium. Alkylation of the N-terminal half resulted in biphasic calcium release with rates (kobs 153 s-1 and 10.9 s-1 respectively) similar to those observed in intact alkylated calmodulin. The rates of calcium dissociation from calmodulin-melittin or fragment-melittin complexes, measured with Quin 2, were slower and monophasic in the C-terminal half (kobs 1.12 s-1), biphasic in the N-terminal half (kobs 140 s-1 and 26.8 s-1 respectively) and triphasic in intact calmodulin (kobs 126 s-1, 12.1 s-1 and 1.38 s-1). Calmodulin antagonists thus increase the apparent calcium affinity of high and low-affinity sites mainly due to a reduced calcium 'off rate', presumably because of conformation restrictions.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

使用钙螯合剂喹啉2通过停流荧光法直接测定了钙调蛋白C端和N端、完整牛脑钙调蛋白以及各自的苯氧苄胺复合物或蜂毒肽复合物中钙的解离情况,并且在可能的情况下,还通过与乙二醇双(2-氨基乙基醚)四乙酸(EGTA)混合利用内源性酪氨酸荧光的蛋白质荧光法进行了测定。钙从仅含有两个高亲和力钙结合位点的钙调蛋白C端以及完整钙调蛋白中的解离是单相的,两种方法获得的钙解离速率具有良好的相关性。在C端,喹啉2法和内源性酪氨酸荧光法测得的表观速率分别为13.4 s⁻¹和12.8 s⁻¹,在完整钙调蛋白中分别为10.5 s⁻¹和10.8 s⁻¹(pH 7.0,25℃,100 mM氯化钾)。C端的烷基化导致钙解离呈双相(喹啉2法:观测速率分别为1.90 s⁻¹和0.73 s⁻¹;酪氨酸法:观测速率分别为1.65 s⁻¹和0.61 s⁻¹)。完整钙调蛋白的烷基化导致用喹啉2测得的钙解离呈四相(观测速率为85.3 s⁻¹、11.1 s⁻¹、1.92 s⁻¹和0.59 s⁻¹);后两个阶段被认为代表钙从高亲和力位点的释放,因为它们与完整烷基化钙调蛋白中酪氨酸荧光的双相变化相对应(观测速率分别为2.04 s⁻¹和0.53 s⁻¹)以及在C端测定的速率参数。显然,烷基化对钙结合位点的扰动降低了钙解离速率,并使得能够区分从两个高亲和力位点各自的解离以及每次钙解离时不同的构象变化。N端的烷基化导致钙释放呈双相,其速率(观测速率分别为153 s⁻¹和10.9 s⁻¹)与在完整烷基化钙调蛋白中观察到的相似。用喹啉2测得的钙从钙调蛋白 - 蜂毒肽或片段 - 蜂毒肽复合物中的解离速率在C端较慢且为单相(观测速率为1.12 s⁻¹),在N端为双相(观测速率分别为140 s⁻¹和26.8 s⁻¹),在完整钙调蛋白中为三相(观测速率为126 s⁻¹、12.1 s⁻¹和1.38 s⁻¹)。因此,钙调蛋白拮抗剂主要通过降低钙的“解离速率”来增加高亲和力和低亲和力位点的表观钙亲和力,这可能是由于构象限制所致。(摘要截短于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验